The Happiest Baby, Inc. SNOO Postmarket Surveillance Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHappiest Baby, Inc.
About this trial
This postmarket surveillance study will evaluate the safety of the SNOO Smart Sleeper Bassinet when used for infants who are at high risk for Sudden Unexpected Infant Death (SUID). This study will survey 1000 caregivers of high-risk infants to examine the frequency of death or serious injury occurring in the SNOO Bassinet.
Eligibility criteria
Qualifiers
Respondent must identify as a primary caregiver of the infant.
Purchase or rental of SNOO shipped to a U.S. residence during the defined enrollment period.
Caregivers must be English speakers ages 18 or older residing in the United States.
Infants must use SNOO during the intended use period (i.e., birth to 6 months).
Disqualifiers
Not primary caregiver
Does not speak English
Is not a US resident
Is not 18 years old or older
Trial design
Treatments tested in this trial
- SNOO Bassinet
Treatment groups
1,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov